19 June 2013
Keywords: alrt, oral, lekemia, drug, effective, interim, results
Article | 27 May 1996
Interim results from a Phase I/II trial of Allergan Ligand Retinoid Therapeutics' 9-cis-retinoic acid product, ALRT1057, have revealed that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.